Urinary polycyclic aromatic hydrocarbons and childhood obesity: NHANES (2001-2006)
- PMID: 24380973
- PMCID: PMC3948036
- DOI: 10.1289/ehp.1307234
Urinary polycyclic aromatic hydrocarbons and childhood obesity: NHANES (2001-2006)
Abstract
Background: Polycyclic aromatic hydrocarbons (PAHs) are known carcinogens and suspected endocrine disruptors. Prenatal exposure to PAHs has been associated with obesity in early childhood.
Objective: We examined the association of urinary PAH metabolites with adiposity outcomes [body mass index (BMI) z-score, waist circumference (WC), and rate of obesity] in children and adolescents.
Methods: We performed whole-sample analyses of 3,189 individuals 6-19 years of age who participated in the 2001-2006 National Health and Nutrition Examination Survey. We performed multivariate linear and logistic regression to analyze the association of BMI z-score, WC, and obesity with concentrations of single urinary PAH compounds and the sum of PAHs. Furthermore, the analyses were stratified by developmental stage [i.e., children (6-11 years) and adolescents (12-19 years)].
Results: BMI z-score, WC, and obesity were positively associated with the molecular mass sum of the PAHs and the total sum of naphthalene metabolites. Most associations increased monotonically with increasing quartiles of exposure among children 6-11 years of age, whereas dose-response trends were less consistent for adolescents (12-19 years of age). Neither total PAHs nor total naphthalene metabolites were associated with overweight in either age group, and there was little evidence of associations between the outcomes and individual PAHs.
Conclusions: Total urinary PAH metabolites and naphthalene metabolites were associated with higher BMI, WC, and obesity in children 6-11 years of age, with positive but less consistent associations among adolescents.
Citation: Scinicariello F, Buser MC. 2014. Urinary polycyclic aromatic hydrocarbons and childhood obesity: NHANES (2001-2006). Environ Health Perspect 122:299-303; http://dx.doi.org/10.1289/ehp.1307234.
Conflict of interest statement
The findings and conclusion in this report are those of the authors and do not necessarily represent the views of CDC/Agency for Toxic Substances and Disease Registry.
The authors declare they have no actual or potential competing financial interests.
References
-
- ATSDR (Agency for Toxic Substances and Disease Registry). Atlanta, GA: ATSDR; 1995. Toxicological Profile for Polycyclic Aromatic Hydrocarbons (PAHs) - PubMed
-
- ATSDR (Agency for Toxic Substances and Disease Registry). Atlanta, GA: ATSDR; 2005. Toxicological Profile for Naphthalene, 1-Methylnaphthalene, and 2-Methylnaphthalene.
-
- Baxter JD, Webb P, Grover G, Scanlan TS. Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends Endocrinol Metab. 2004;15:154–157. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical